HomeBBIO • NASDAQ
Follow
BridgeBio Pharma Inc
Previous close
$30.86
Year range
$12.75 - $44.32
Market cap
5.67B USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.74M | -6.68% |
Operating expense | 177.81M | 44.84% |
Net income | -168.15M | -22.21% |
Net profit margin | -9.64K | -30.96% |
Earnings per share | -0.96 | -10.31% |
EBITDA | -175.08M | -46.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 434.88M | -7.85% |
Total assets | 546.38M | -12.30% |
Total liabilities | 1.89B | 1.12% |
Total equity | -1.34B | — |
Shares outstanding | 175.83M | — |
Price to book | -3.99 | — |
Return on assets | -73.52% | — |
Return on capital | -94.11% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -168.15M | -22.21% |
Cash from operations | -124.82M | -33.86% |
Cash from investing | -66.00K | -100.37% |
Cash from financing | -4.52M | -170.93% |
Net change in cash | -129.41M | -87.82% |
Free cash flow | -45.31M | 49.14% |
About
CEO
Founded
2015
Headquarters
Website
Employees
553